Skip to main content
Erschienen in: Cellular Oncology 2/2019

12.02.2019 | Original Paper

Secretome profiling of heterotypic spheroids suggests a role of fibroblasts in HIF-1 pathway modulation and colorectal cancer photodynamic resistance

verfasst von: María Julia Lamberti, Mandy Rettel, Jeroen Krijgsveld, Viviana Alicia Rivarola, Natalia Belén Rumie Vittar

Erschienen in: Cellular Oncology | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Previous analyses of the tumor microenvironment (TME) have resulted in a concept that tumor progression may depend on interactions between cancer cells and its surrounding stroma. An important aspect of these interactions is the ability of cancer cells to modulate stroma behavior, and vice versa, through the action of a variety of soluble mediators. Here, we aimed to identify soluble factors present in the TME of colorectal cancer cells that may affect relevant pathways through secretome profiling.

Methods

To partially recapitulate the TME and its architecture, we co-cultured colorectal cancer cells (SW480, TC) with stromal fibroblasts (MRC-5, F) as 3D-spheroids. Subsequent characterization of both homotypic (TC) and heterotypic (TC + F) spheroid secretomes was performed using label-free liquid chromatography-mass spectrometry (LC-MS).

Results

Through bioinformatic analysis using the NCI-Pathway Interaction Database (NCI-PID) we found that the HIF-1 signaling pathway was most highly enriched among the proteins whose secretion was enhanced in the heterotypic spheroids. Previously, we found that HIF-1 may be associated with resistance of colorectal cancer cells to photodynamic therapy (PDT), an antitumor therapy that combines photosensitizing agents, O2 and light to create a harmful photochemical reaction. Here, we found that the presence of fibroblasts considerably diminished the sensitivity of colorectal cancer cells to photodynamic activity. Although the biological significance of the HIF-1 pathway of secretomes was decreased after photosensitization, this decrease was partially reversed in heterotypic 3D-spheroids. HIF-1 pathway modulation by both PDT and stromal fibroblasts was confirmed through expression assessment of the HIF-target VEGF, as well as through HIF transcriptional activity assessment.

Conclusion

Collectively, our results delineate a potential mechanism by which stromal fibroblasts may enhance colorectal cancer cell survival and photodynamic treatment resistance via HIF-1 pathway modulation.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat P. Nilendu, S. Sarode, D. Jahagirdar, I. Tandon, S. Patil, G. Sarode, J. Pal, N. Sharma, Mutual concessions and compromises between stromal cells and cancer cells: Driving tumor development and drug resistance. Cell. Oncol. 41, 353 (2018)CrossRef P. Nilendu, S. Sarode, D. Jahagirdar, I. Tandon, S. Patil, G. Sarode, J. Pal, N. Sharma, Mutual concessions and compromises between stromal cells and cancer cells: Driving tumor development and drug resistance. Cell. Oncol. 41, 353 (2018)CrossRef
2.
Zurück zum Zitat N. Eiro, L. González, A. Martínez-Ordoñez, B. Fernandez-Garcia, L. González, S. Cid, F. Dominguez, R. Perez-Fernandez, F. Vizoso, Cancer-associated fibroblasts affect breast cancer cell gene expression, invasion and angiogenesis. Cell. Oncol. 41, 369 (2018)CrossRef N. Eiro, L. González, A. Martínez-Ordoñez, B. Fernandez-Garcia, L. González, S. Cid, F. Dominguez, R. Perez-Fernandez, F. Vizoso, Cancer-associated fibroblasts affect breast cancer cell gene expression, invasion and angiogenesis. Cell. Oncol. 41, 369 (2018)CrossRef
3.
Zurück zum Zitat P. Cirri, P. Chiarugi, Cancer-associated-fibroblasts and tumour cells: A diabolic liaison driving cancer progression. Cancer Metastasis Rev. 31, 195 (2012)CrossRefPubMed P. Cirri, P. Chiarugi, Cancer-associated-fibroblasts and tumour cells: A diabolic liaison driving cancer progression. Cancer Metastasis Rev. 31, 195 (2012)CrossRefPubMed
4.
Zurück zum Zitat J. Paltridge, L. Belle, Y. Khew-Goodall, Advances in the proteomic investigation of the cell secretome. Biochim. Biophys. Acta 1834, 2233 (2013)CrossRefPubMed J. Paltridge, L. Belle, Y. Khew-Goodall, Advances in the proteomic investigation of the cell secretome. Biochim. Biophys. Acta 1834, 2233 (2013)CrossRefPubMed
5.
Zurück zum Zitat K. Brown, C. Formolo, H. Seol, R. Marathi, S. Duguez, E. An, D. Pillai, J. Nazarian, B. Rood, Y. Hathout, Advances in the proteomic investigation of the cell secretome. Expert Rev. Proteomics 9, 337 (2012)CrossRefPubMedPubMedCentral K. Brown, C. Formolo, H. Seol, R. Marathi, S. Duguez, E. An, D. Pillai, J. Nazarian, B. Rood, Y. Hathout, Advances in the proteomic investigation of the cell secretome. Expert Rev. Proteomics 9, 337 (2012)CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat D. Hanahan, L. Coussens, Accessories to the crime: Functions of cells recruited to the tumor microenvironment. Cancer Cell 21, 309 (2012)CrossRefPubMed D. Hanahan, L. Coussens, Accessories to the crime: Functions of cells recruited to the tumor microenvironment. Cancer Cell 21, 309 (2012)CrossRefPubMed
7.
8.
Zurück zum Zitat P. Agostinis, E. Buytaert, H. Breyssens, N. Hendrickx, Regulatory pathways in photodynamic therapy induced apoptosis. Photochem. Photobiol. Sci. 3, 721 (2004)CrossRefPubMed P. Agostinis, E. Buytaert, H. Breyssens, N. Hendrickx, Regulatory pathways in photodynamic therapy induced apoptosis. Photochem. Photobiol. Sci. 3, 721 (2004)CrossRefPubMed
9.
Zurück zum Zitat N. Rumie Vittar, M. Lamberti, M. Pansa, R. Vera, M. Rodriguez, I. Cogno, L. Milla Sanabria, V. Rivarola, Ecological photodynamic therapy: New trend to disrupt the intricate networks within tumor ecosystem. Biochim. Biophys. Acta 1835, 86 (2013)PubMed N. Rumie Vittar, M. Lamberti, M. Pansa, R. Vera, M. Rodriguez, I. Cogno, L. Milla Sanabria, V. Rivarola, Ecological photodynamic therapy: New trend to disrupt the intricate networks within tumor ecosystem. Biochim. Biophys. Acta 1835, 86 (2013)PubMed
10.
Zurück zum Zitat A. Kawczyk-Krupka, A. Bugaj, W. Latos, K. Zaremba, K. Wawrzyniec, A. Sieroń, Photodynamic therapy in colorectal cancer treatment: The state of the art in clinical trials. Photodiagn. Photodyn. Ther. 12, 545 (2015)CrossRef A. Kawczyk-Krupka, A. Bugaj, W. Latos, K. Zaremba, K. Wawrzyniec, A. Sieroń, Photodynamic therapy in colorectal cancer treatment: The state of the art in clinical trials. Photodiagn. Photodyn. Ther. 12, 545 (2015)CrossRef
11.
Zurück zum Zitat M. Lamberti, M. Pansa, R. Vera, M. Fernandez-Zapico, N. Rumie Vittar, V. Rivarola, Transcriptional activation of HIF-1 by a ROS-ERK axis underlies the resistance to photodynamic therapy. PLoS One 12, e0177801 (2017)CrossRefPubMedPubMedCentral M. Lamberti, M. Pansa, R. Vera, M. Fernandez-Zapico, N. Rumie Vittar, V. Rivarola, Transcriptional activation of HIF-1 by a ROS-ERK axis underlies the resistance to photodynamic therapy. PLoS One 12, e0177801 (2017)CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat M. Rodríguez, C. Catrinacio, A. Ropolo, V. Rivarola, M. Vaccaro, A novel HIF-1α/VMP1-autophagic pathway induces resistance to photodynamic therapy in colon cancer cells. Photochem. Photobiol. Sci. 16, 1631 (2017)CrossRefPubMed M. Rodríguez, C. Catrinacio, A. Ropolo, V. Rivarola, M. Vaccaro, A novel HIF-1α/VMP1-autophagic pathway induces resistance to photodynamic therapy in colon cancer cells. Photochem. Photobiol. Sci. 16, 1631 (2017)CrossRefPubMed
13.
Zurück zum Zitat U. Brockmeier, C. Platzek, K. Schneider, P. Patak, A. Bernardini, J. Fandrey, E. Metzen, The function of hypoxia-inducible factor (HIF) is independent of the endoplasmic reticulum protein OS-9. PLoS One 6, e19151 (2011)CrossRefPubMedPubMedCentral U. Brockmeier, C. Platzek, K. Schneider, P. Patak, A. Bernardini, J. Fandrey, E. Metzen, The function of hypoxia-inducible factor (HIF) is independent of the endoplasmic reticulum protein OS-9. PLoS One 6, e19151 (2011)CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat M. Pansa, M. Lamberti, I. Cogno, S. Correa, N. Rumie Vittar, V. Rivarola, Contribution of resident and recruited macrophages to the photodynamic intervention of colorectal tumor microenvironment. Tumour Biol. 37, 541 (2016)CrossRefPubMed M. Pansa, M. Lamberti, I. Cogno, S. Correa, N. Rumie Vittar, V. Rivarola, Contribution of resident and recruited macrophages to the photodynamic intervention of colorectal tumor microenvironment. Tumour Biol. 37, 541 (2016)CrossRefPubMed
15.
Zurück zum Zitat W. Metzger, D. Sossong, A. Bächle, N. Pütz, G. Wennemuth, T. Pohlemann, M. Oberringer, The liquid overlay technique is the key to formation of co-culture spheroids consisting of primary osteoblasts, fibroblasts and endothelial cells. Cytotherapy 13, 1000 (2011)CrossRefPubMed W. Metzger, D. Sossong, A. Bächle, N. Pütz, G. Wennemuth, T. Pohlemann, M. Oberringer, The liquid overlay technique is the key to formation of co-culture spheroids consisting of primary osteoblasts, fibroblasts and endothelial cells. Cytotherapy 13, 1000 (2011)CrossRefPubMed
16.
Zurück zum Zitat M. Lamberti, M. Pansa, R. Vera, N. Rumie Vittar, V. Rivarola, Photodynamic therapy potentiates the paracrine endothelial stimulation by colorectal cancer. Laser Phys. 24, 8 (2014)CrossRef M. Lamberti, M. Pansa, R. Vera, N. Rumie Vittar, V. Rivarola, Photodynamic therapy potentiates the paracrine endothelial stimulation by colorectal cancer. Laser Phys. 24, 8 (2014)CrossRef
17.
Zurück zum Zitat G. Comito, E. Giannoni, P. Di Gennaro, C. Segura, G. Gerlini, P. Chiarugi, Stromal fibroblasts synergize with hypoxic oxidative stress to enhance melanoma aggressiveness. Cancer Lett. 324, 31 (2012)CrossRefPubMed G. Comito, E. Giannoni, P. Di Gennaro, C. Segura, G. Gerlini, P. Chiarugi, Stromal fibroblasts synergize with hypoxic oxidative stress to enhance melanoma aggressiveness. Cancer Lett. 324, 31 (2012)CrossRefPubMed
18.
Zurück zum Zitat C. Hughes, S. Foehr, D. Garfield, E. Furlong, L. Steinmetz, J. Krijgsveld, Ultrasensitive proteome analysis using paramagnetic bead technology. Mol. Syst. Biol. 10, 10 (2014)CrossRef C. Hughes, S. Foehr, D. Garfield, E. Furlong, L. Steinmetz, J. Krijgsveld, Ultrasensitive proteome analysis using paramagnetic bead technology. Mol. Syst. Biol. 10, 10 (2014)CrossRef
19.
Zurück zum Zitat J. Gouw, J. Krijgsveld, MSQuant: A platform for stable isotope-based quantitative proteomics. Methods Mol. Biol. 893, 511 (2012)CrossRefPubMed J. Gouw, J. Krijgsveld, MSQuant: A platform for stable isotope-based quantitative proteomics. Methods Mol. Biol. 893, 511 (2012)CrossRefPubMed
20.
Zurück zum Zitat M. Arntzen, I. Karlskås, M. Skaugen, V. Eijsink, G. Mathiesen, Proteomic investigation of the response of enterococcus faecalis V583 when cultivated in urine. PLoS One 10, e0126694 (2015)CrossRefPubMedPubMedCentral M. Arntzen, I. Karlskås, M. Skaugen, V. Eijsink, G. Mathiesen, Proteomic investigation of the response of enterococcus faecalis V583 when cultivated in urine. PLoS One 10, e0126694 (2015)CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Y. Zhang, Z. Dong, D. Wang, Y. Wu, Q. Song, P. Gu, P. Zhao, Q. Xia, Proteomics of larval hemolymph in Bombyx mori reveals various nutrient-storage and immunity-related proteins. Amino Acids 46, 1021 (2014)CrossRefPubMed Y. Zhang, Z. Dong, D. Wang, Y. Wu, Q. Song, P. Gu, P. Zhao, Q. Xia, Proteomics of larval hemolymph in Bombyx mori reveals various nutrient-storage and immunity-related proteins. Amino Acids 46, 1021 (2014)CrossRefPubMed
22.
Zurück zum Zitat J. Bendtsen, L. Jensen, N. Blom, G. Von Heijne, S. Brunak, Eature-based prediction of non-classical and leaderless protein secretion. Protein Eng. Des. Sel. 17, 349 (2004)CrossRefPubMed J. Bendtsen, L. Jensen, N. Blom, G. Von Heijne, S. Brunak, Eature-based prediction of non-classical and leaderless protein secretion. Protein Eng. Des. Sel. 17, 349 (2004)CrossRefPubMed
23.
Zurück zum Zitat T. Petersen, S. Brunak, G. von Heijne, H. Nielsen, SignalP 4.0: Discriminating signal peptides from transmembrane regions. Nat. Methods 8, 785 (2011)CrossRefPubMed T. Petersen, S. Brunak, G. von Heijne, H. Nielsen, SignalP 4.0: Discriminating signal peptides from transmembrane regions. Nat. Methods 8, 785 (2011)CrossRefPubMed
24.
Zurück zum Zitat C. von Mering, M. Huynen, D. Jaeggi, S. Schmidt, P. Bork, B. Snel, STRING: A database of predicted functional associations between proteins. Nucleic Acids Res. 31, 258 (2003)CrossRef C. von Mering, M. Huynen, D. Jaeggi, S. Schmidt, P. Bork, B. Snel, STRING: A database of predicted functional associations between proteins. Nucleic Acids Res. 31, 258 (2003)CrossRef
25.
Zurück zum Zitat C. Schaefer, K. Anthony, S. Krupa, J. Buchoff, M. Day, T. Hannay, K. Buetow, PID: The pathway interaction database. Nucleic Acids Res. 37, D674 (2009)CrossRefPubMed C. Schaefer, K. Anthony, S. Krupa, J. Buchoff, M. Day, T. Hannay, K. Buetow, PID: The pathway interaction database. Nucleic Acids Res. 37, D674 (2009)CrossRefPubMed
26.
Zurück zum Zitat M. Ashburner, C. Ball, J. Blake, D. Botstein, H. Butler, J. Cherry, A. Davis, K. Dolinski, S. Dwight, J. Eppig, M. Harris, D. Hill, L. Issel-Tarver, A. Kasarskis, S. Lewis, J. Matese, J. Richardson, M. Ringwald, G. Rubin, G. Sherlock, Gene ontology: Tool for the unification of biology. The gene ontology consortium. Nat. Genet. 25, 25 (2000)CrossRefPubMedPubMedCentral M. Ashburner, C. Ball, J. Blake, D. Botstein, H. Butler, J. Cherry, A. Davis, K. Dolinski, S. Dwight, J. Eppig, M. Harris, D. Hill, L. Issel-Tarver, A. Kasarskis, S. Lewis, J. Matese, J. Richardson, M. Ringwald, G. Rubin, G. Sherlock, Gene ontology: Tool for the unification of biology. The gene ontology consortium. Nat. Genet. 25, 25 (2000)CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat M. Lamberti, N. Rumie Vittar, F. de Carvalho da Silva, V. Ferreira, V. Rivarola, Synergistic enhancement of antitumor effect of B-Lapachone by photodynamic induction of quinone oxidoreductase (NQO1). Phytomedicine 20, 1007 (2013)CrossRefPubMed M. Lamberti, N. Rumie Vittar, F. de Carvalho da Silva, V. Ferreira, V. Rivarola, Synergistic enhancement of antitumor effect of B-Lapachone by photodynamic induction of quinone oxidoreductase (NQO1). Phytomedicine 20, 1007 (2013)CrossRefPubMed
28.
Zurück zum Zitat C. Hellweg, C. Baumstark-Khan, G. Horneck, Enhanced green fluorescent protein as reporter protein for biomonitoring of cytotoxic effects in mammalian cells. Anal. Chim. Acta 427, 191 (2001)CrossRef C. Hellweg, C. Baumstark-Khan, G. Horneck, Enhanced green fluorescent protein as reporter protein for biomonitoring of cytotoxic effects in mammalian cells. Anal. Chim. Acta 427, 191 (2001)CrossRef
29.
Zurück zum Zitat L. Milla, I. Cogno, M. Rodríguez, F. Sanz-Rodríguez, A. Zamarrón, Y. Gilaberte, E. Carrasco, V. Rivarola, A. Juarranz, Isolation and characterization of squamous carcinoma cells resistant to photodynamic therapy. J. Cell. Biochem. 112, 2266 (2011)CrossRefPubMed L. Milla, I. Cogno, M. Rodríguez, F. Sanz-Rodríguez, A. Zamarrón, Y. Gilaberte, E. Carrasco, V. Rivarola, A. Juarranz, Isolation and characterization of squamous carcinoma cells resistant to photodynamic therapy. J. Cell. Biochem. 112, 2266 (2011)CrossRefPubMed
30.
31.
Zurück zum Zitat C. Koumenis, L. Coussens, A. Giaccia, E. Hammond, Tumor Microenvironment: Study Protocols, vol. 899 (Springer, 2016) C. Koumenis, L. Coussens, A. Giaccia, E. Hammond, Tumor Microenvironment: Study Protocols, vol. 899 (Springer, 2016)
32.
Zurück zum Zitat T. Tsujino, I. Seshimo, H. Yamamoto, C. Ngan, K. Ezumi, I. Takemasa, M. Ikeda, M. Sekimoto, N. Matsuura, M. Monden, Stromal myofibroblasts predict disease recurrence for colorectal cancer. Clin. Cancer Res. 13, 2082 (2007)CrossRefPubMed T. Tsujino, I. Seshimo, H. Yamamoto, C. Ngan, K. Ezumi, I. Takemasa, M. Ikeda, M. Sekimoto, N. Matsuura, M. Monden, Stromal myofibroblasts predict disease recurrence for colorectal cancer. Clin. Cancer Res. 13, 2082 (2007)CrossRefPubMed
33.
Zurück zum Zitat G. Karagiannis, M. Pavlou, E. Diamandis, Cancer secretomics reveal pathophysiological pathways in cancer molecular oncology. Mol. Oncol. 4, 496 (2010)CrossRefPubMedPubMedCentral G. Karagiannis, M. Pavlou, E. Diamandis, Cancer secretomics reveal pathophysiological pathways in cancer molecular oncology. Mol. Oncol. 4, 496 (2010)CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat H. Soares, J. Campos, L. Gomes-da-Silva, F. Schaberle, J. Dabrowski, L. Arnaut, Pro-oxidant and antioxidant effects in photodynamic therapy: Cells recognise that not all exogenous ROS are alike. Chembiochem 17, 836 (2016)CrossRefPubMed H. Soares, J. Campos, L. Gomes-da-Silva, F. Schaberle, J. Dabrowski, L. Arnaut, Pro-oxidant and antioxidant effects in photodynamic therapy: Cells recognise that not all exogenous ROS are alike. Chembiochem 17, 836 (2016)CrossRefPubMed
35.
Zurück zum Zitat M.D. Glidden, I. Massodi, I. Rizvi, J.P. Celli, T. Hasan, Probing tumor-stroma interactions and response to photodynamic therapy in a 3D pancreatic cancer-fibroblast co-culture model. Proc. SPIE 8210, 821006 (2012)CrossRef M.D. Glidden, I. Massodi, I. Rizvi, J.P. Celli, T. Hasan, Probing tumor-stroma interactions and response to photodynamic therapy in a 3D pancreatic cancer-fibroblast co-culture model. Proc. SPIE 8210, 821006 (2012)CrossRef
36.
Zurück zum Zitat K. Lauber, A. Ernst, M. Orth, M. Herrmann, C. Belka, Dying cell clearance and its impact on the outcome of tumor radiotherapy. Front. Oncol. 2, 116 (2012)CrossRefPubMedPubMedCentral K. Lauber, A. Ernst, M. Orth, M. Herrmann, C. Belka, Dying cell clearance and its impact on the outcome of tumor radiotherapy. Front. Oncol. 2, 116 (2012)CrossRefPubMedPubMedCentral
37.
Zurück zum Zitat V. Carroll, M. Ashcroft, Role of hypoxia-inducible factor (HIF)-1alpha versus HIF-2alpha in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-I, or loss of von Hippel-Lindau function: Implications for targeting the HIF pathway. Cancer Res. 66, 6264 (2006)CrossRefPubMed V. Carroll, M. Ashcroft, Role of hypoxia-inducible factor (HIF)-1alpha versus HIF-2alpha in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-I, or loss of von Hippel-Lindau function: Implications for targeting the HIF pathway. Cancer Res. 66, 6264 (2006)CrossRefPubMed
38.
40.
Zurück zum Zitat M. Zanoni, F. Piccinini, C. Arienti, A. Zamagni, S. Santi, R. Polico, A. Bevilacqua, A. Tesei, 3D tumor spheroid models for in vitro therapeutic screening: A systematic approach to enhance the biological relevance of data obtained. Sci. Rep. 6, 19103 (2016)CrossRefPubMedPubMedCentral M. Zanoni, F. Piccinini, C. Arienti, A. Zamagni, S. Santi, R. Polico, A. Bevilacqua, A. Tesei, 3D tumor spheroid models for in vitro therapeutic screening: A systematic approach to enhance the biological relevance of data obtained. Sci. Rep. 6, 19103 (2016)CrossRefPubMedPubMedCentral
41.
Zurück zum Zitat A. Amann, M. Zwierzina, G. Gamerith, M. Bitsche, J. Huber, G. Vogel, M. Blumer, S. Koeck, E. Pechriggl, J. Kelm, W. Hilbe, H. Zwierzina, Development of an innovative 3D cell culture system to study tumour--stroma interactions in non-small cell lung cancer cells. PLoS One 9, e92511 (2014)CrossRefPubMedPubMedCentral A. Amann, M. Zwierzina, G. Gamerith, M. Bitsche, J. Huber, G. Vogel, M. Blumer, S. Koeck, E. Pechriggl, J. Kelm, W. Hilbe, H. Zwierzina, Development of an innovative 3D cell culture system to study tumour--stroma interactions in non-small cell lung cancer cells. PLoS One 9, e92511 (2014)CrossRefPubMedPubMedCentral
42.
Zurück zum Zitat L. Villarreal, O. Méndez, C. Salvans, J. Gregori, J. Baselga, J. Villanueva, Unconventional secretion is a major contributor of cancer cell line secretomes. Mol. Cell. Proteomics 12, 1046 (2013)CrossRefPubMed L. Villarreal, O. Méndez, C. Salvans, J. Gregori, J. Baselga, J. Villanueva, Unconventional secretion is a major contributor of cancer cell line secretomes. Mol. Cell. Proteomics 12, 1046 (2013)CrossRefPubMed
43.
Zurück zum Zitat G. Butler, C. Overall, proteomic identification of multitasking proteins in unexpected locations complicates drug targeting. Nat. Rev. Drug Discov. 8, 935 (2009)CrossRefPubMed G. Butler, C. Overall, proteomic identification of multitasking proteins in unexpected locations complicates drug targeting. Nat. Rev. Drug Discov. 8, 935 (2009)CrossRefPubMed
44.
Zurück zum Zitat D. Radisky, M. Stallings-Mann, Y. Hirai, M. Bissell, Single proteins might have dual but related functions in intracellular and extracellular microenvironments. Nat. Rev. Mol. Cell Biol. 10, 228 (2009)CrossRefPubMedPubMedCentral D. Radisky, M. Stallings-Mann, Y. Hirai, M. Bissell, Single proteins might have dual but related functions in intracellular and extracellular microenvironments. Nat. Rev. Mol. Cell Biol. 10, 228 (2009)CrossRefPubMedPubMedCentral
45.
Zurück zum Zitat D. Fukumura, R. Xavier, T. Sugiura, Y. Chen, E. Park, N. Lu, M. Selig, G. Nielsen, T. Taksir, R. Jain, B. Seed, Tumor induction of VEGF promoter activity in stromal cells. Cell 94, 715 (1998)CrossRefPubMed D. Fukumura, R. Xavier, T. Sugiura, Y. Chen, E. Park, N. Lu, M. Selig, G. Nielsen, T. Taksir, R. Jain, B. Seed, Tumor induction of VEGF promoter activity in stromal cells. Cell 94, 715 (1998)CrossRefPubMed
47.
Zurück zum Zitat C. Holohan, S. Van Schaeybroeck, D. Longley, P. Johnston, Cancer drug resistance: An evolving paradigm. Nat. Rev. Cancer 13, 714 (2013)CrossRefPubMed C. Holohan, S. Van Schaeybroeck, D. Longley, P. Johnston, Cancer drug resistance: An evolving paradigm. Nat. Rev. Cancer 13, 714 (2013)CrossRefPubMed
48.
Zurück zum Zitat S. Jung, H. Song, S. Park, S. Chung, Y. Kim, Pyruvate promotes tumor angiogenesis through HIF-1-dependent PAI-1 expression. Int. J. Oncol. 38, 571 (2011)PubMed S. Jung, H. Song, S. Park, S. Chung, Y. Kim, Pyruvate promotes tumor angiogenesis through HIF-1-dependent PAI-1 expression. Int. J. Oncol. 38, 571 (2011)PubMed
49.
Zurück zum Zitat Y. Ahn, M. Chua, J.J. Whitlock, Y. Shin, W. Song, Y. Kim, C. Eom, W. An, Rodent-specific hypoxia response elements enhance PAI-1 expression through HIF-1 or HIF-2 in mouse hepatoma cells. Int. J. Oncol. 37, 1627 (2010)PubMed Y. Ahn, M. Chua, J.J. Whitlock, Y. Shin, W. Song, Y. Kim, C. Eom, W. An, Rodent-specific hypoxia response elements enhance PAI-1 expression through HIF-1 or HIF-2 in mouse hepatoma cells. Int. J. Oncol. 37, 1627 (2010)PubMed
50.
Zurück zum Zitat S. Peng, G. Xue, L. Gong, C. Fang, J. Chen, C. Yuan, Z. Chen, L. Yao, B. Furie, M. Huang, A long-acting PAI-1 inhibitor reduce thrombus formation. Thromb. Haemost. 117, 1338 (2017) S. Peng, G. Xue, L. Gong, C. Fang, J. Chen, C. Yuan, Z. Chen, L. Yao, B. Furie, M. Huang, A long-acting PAI-1 inhibitor reduce thrombus formation. Thromb. Haemost. 117, 1338 (2017)
51.
Zurück zum Zitat G. McMahon, E. Petitclerc, S. Stefansson, E. Smith, M. Wong, R. Westrick, D. Ginsburg, P. Brooks, D. Lawrence, Plasminogen activator inhibitor-1 regulates tumor growth and angiogenesis. J. Biol. Chem. 276, 33964 (2001)CrossRefPubMed G. McMahon, E. Petitclerc, S. Stefansson, E. Smith, M. Wong, R. Westrick, D. Ginsburg, P. Brooks, D. Lawrence, Plasminogen activator inhibitor-1 regulates tumor growth and angiogenesis. J. Biol. Chem. 276, 33964 (2001)CrossRefPubMed
52.
Zurück zum Zitat C. Isogai, W. Laug, H. Shimada, P. Declerck, M. Stins, D. Durden, A. Erdreich-Epstein, Y. DeClerck, Plasminogen activator inhibitor-1 promotes angiogenesis by stimulating endothelial cell migration toward fibronectin. Cancer Res. 61, 5587 (2001)PubMed C. Isogai, W. Laug, H. Shimada, P. Declerck, M. Stins, D. Durden, A. Erdreich-Epstein, Y. DeClerck, Plasminogen activator inhibitor-1 promotes angiogenesis by stimulating endothelial cell migration toward fibronectin. Cancer Res. 61, 5587 (2001)PubMed
53.
Zurück zum Zitat R. Gozzelino, P. Arosio, Iron homeostasis in health and disease. Int. J. Mol. Sci. 17, (2016) R. Gozzelino, P. Arosio, Iron homeostasis in health and disease. Int. J. Mol. Sci. 17, (2016)
54.
Zurück zum Zitat I. Toth, L. Yuan, J. Rogers, H. Boyce, K. Bridges, Hypoxia alters iron-regulatory protein-1 binding capacity and modulates cellular iron homeostasis in human hepatoma and erythroleukemia cells. J. Biol. Chem. 274, 4467 (1999)CrossRefPubMed I. Toth, L. Yuan, J. Rogers, H. Boyce, K. Bridges, Hypoxia alters iron-regulatory protein-1 binding capacity and modulates cellular iron homeostasis in human hepatoma and erythroleukemia cells. J. Biol. Chem. 274, 4467 (1999)CrossRefPubMed
55.
Zurück zum Zitat L. Tacchini, L. Bianchi, A. Bernelli-Zazzera, G. Cairo, Transferrin receptor induction by hypoxia. HIF-1-mediated transcriptional activation and cell-specific post-transcriptional regulation. J. Biol. Chem. 274, 24142 (1999)CrossRefPubMed L. Tacchini, L. Bianchi, A. Bernelli-Zazzera, G. Cairo, Transferrin receptor induction by hypoxia. HIF-1-mediated transcriptional activation and cell-specific post-transcriptional regulation. J. Biol. Chem. 274, 24142 (1999)CrossRefPubMed
56.
Zurück zum Zitat L. Tacchini, E. Gammella, C. De Ponti, S. Recalcati, G. Cairo, Role of HIF-1 and NF-kappaB transcription factors in the modulation of transferrin receptor by inflammatory and anti-inflammatory signals. J. Biol. Chem. 283, 20674 (2008)CrossRefPubMedPubMedCentral L. Tacchini, E. Gammella, C. De Ponti, S. Recalcati, G. Cairo, Role of HIF-1 and NF-kappaB transcription factors in the modulation of transferrin receptor by inflammatory and anti-inflammatory signals. J. Biol. Chem. 283, 20674 (2008)CrossRefPubMedPubMedCentral
57.
Zurück zum Zitat A. de Gassart, C. Geminard, B. Fevrier, G. Raposo, M. Vidal, Lipid raft-associated protein sorting in exosomes. Blood 102, 4336 (2003)CrossRefPubMed A. de Gassart, C. Geminard, B. Fevrier, G. Raposo, M. Vidal, Lipid raft-associated protein sorting in exosomes. Blood 102, 4336 (2003)CrossRefPubMed
58.
Zurück zum Zitat A. Calzolari, C. Raggi, S. Deaglio, N. Sposi, M. Stafsnes, K. Fecchi, I. Parolini, F. Malavasi, C. Peschle, M. Sargiacomo, U. Testa, TfR2 localizes in lipid raft domains and is released in exosomes to activate signal transduction along the MAPK pathway. J. Cell Sci. Pt 21, 4486 (119AD) A. Calzolari, C. Raggi, S. Deaglio, N. Sposi, M. Stafsnes, K. Fecchi, I. Parolini, F. Malavasi, C. Peschle, M. Sargiacomo, U. Testa, TfR2 localizes in lipid raft domains and is released in exosomes to activate signal transduction along the MAPK pathway. J. Cell Sci. Pt 21, 4486 (119AD)
59.
Zurück zum Zitat M.I. Koukourakis, A. Giatromanolaki, A.L. Harris, E. Sivridis, Comparison of metabolic pathways between cancer cells and stromal cells in colorectal carcinomas: A metabolic survival role for tumor-associated stroma. Cancer Res. 66, 632 (2006)CrossRefPubMed M.I. Koukourakis, A. Giatromanolaki, A.L. Harris, E. Sivridis, Comparison of metabolic pathways between cancer cells and stromal cells in colorectal carcinomas: A metabolic survival role for tumor-associated stroma. Cancer Res. 66, 632 (2006)CrossRefPubMed
60.
Zurück zum Zitat G. van Niekerk, A. Engelbrecht, Role of PKM2 in directing the metabolic fate of glucose in cancer: A potential therapeutic target. Cell. Oncol. 41, 343 (2018)CrossRef G. van Niekerk, A. Engelbrecht, Role of PKM2 in directing the metabolic fate of glucose in cancer: A potential therapeutic target. Cell. Oncol. 41, 343 (2018)CrossRef
61.
Zurück zum Zitat R. Han, F. Wang, P. Zhang, X. Zhou, Y. Li, miR-383 inhibits ovarian cancer cell proliferation, invasion and aerobic glycolysis by targeting LDHA. Neoplasma 64 (2017) R. Han, F. Wang, P. Zhang, X. Zhou, Y. Li, miR-383 inhibits ovarian cancer cell proliferation, invasion and aerobic glycolysis by targeting LDHA. Neoplasma 64 (2017)
62.
Zurück zum Zitat T. He, Y. Zhang, H. Jiang, X. Li, H. Zhu, K. Zheng, The c-Myc-LDHA axis positively regulates aerobic glycolysis and promotes tumor progression in pancreatic cancer. Med. Oncol. 32, 187 (2015)CrossRefPubMedPubMedCentral T. He, Y. Zhang, H. Jiang, X. Li, H. Zhu, K. Zheng, The c-Myc-LDHA axis positively regulates aerobic glycolysis and promotes tumor progression in pancreatic cancer. Med. Oncol. 32, 187 (2015)CrossRefPubMedPubMedCentral
63.
Zurück zum Zitat M. Capello, S. Ferri-Borgogno, P. Cappello, F. Novelli, α-Enolase: A promising therapeutic and diagnostic tumor target. FEBS J. 287, 1064 (2011)CrossRef M. Capello, S. Ferri-Borgogno, P. Cappello, F. Novelli, α-Enolase: A promising therapeutic and diagnostic tumor target. FEBS J. 287, 1064 (2011)CrossRef
64.
Zurück zum Zitat C. Hu, A. Sataur, L. Wang, H. Chen, M. Simon, The N-terminal transactivation domain confers target gene specificity of hypoxia-inducible factors HIF-1alpha and HIF-2alpha. Mol. Biol. Cell 18, 4528 (2007)CrossRefPubMedPubMedCentral C. Hu, A. Sataur, L. Wang, H. Chen, M. Simon, The N-terminal transactivation domain confers target gene specificity of hypoxia-inducible factors HIF-1alpha and HIF-2alpha. Mol. Biol. Cell 18, 4528 (2007)CrossRefPubMedPubMedCentral
65.
Zurück zum Zitat G. Semenza, B. Jiang, S. Leung, R. Passantino, J. Concordet, P. Maire, A. Giallongo, Hypoxia response elements in the aldolase a, enolase 1, and lactate dehydrogenase a gene promoters contain essential binding sites for hypoxia-inducible factor 1. J. Biol. Chem. 27, 32529 (1996)CrossRef G. Semenza, B. Jiang, S. Leung, R. Passantino, J. Concordet, P. Maire, A. Giallongo, Hypoxia response elements in the aldolase a, enolase 1, and lactate dehydrogenase a gene promoters contain essential binding sites for hypoxia-inducible factor 1. J. Biol. Chem. 27, 32529 (1996)CrossRef
66.
Zurück zum Zitat N. Denko, Hypoxia, HIF1 and glucose metabolism in the solid tumour. Nat. Rev. Cancer 8, 705 (2008)CrossRefPubMed N. Denko, Hypoxia, HIF1 and glucose metabolism in the solid tumour. Nat. Rev. Cancer 8, 705 (2008)CrossRefPubMed
67.
Zurück zum Zitat M. Demory Beckler, J. Higginbotham, J. Franklin, A. Ham, P. Halvey, I. Imasuen, C. Whitwell, M. Li, D. Liebler, R. Coffey, Proteomic analysis of exosomes from mutant KRAS colon cancer cells identifies intercellular transfer of mutant KRAS. Mol. Cell. Proteomics 12, 343 (2013)CrossRefPubMed M. Demory Beckler, J. Higginbotham, J. Franklin, A. Ham, P. Halvey, I. Imasuen, C. Whitwell, M. Li, D. Liebler, R. Coffey, Proteomic analysis of exosomes from mutant KRAS colon cancer cells identifies intercellular transfer of mutant KRAS. Mol. Cell. Proteomics 12, 343 (2013)CrossRefPubMed
68.
Zurück zum Zitat R. Xu, D. Greening, A. Rai, H. Ji, R. Simpson, Highly-purified exosomes and shed microvesicles isolated from the human colon cancer cell line LIM1863 by sequential centrifugal ultrafiltration are biochemically and functionally distinct. Methods 87, 11 (2015)CrossRefPubMed R. Xu, D. Greening, A. Rai, H. Ji, R. Simpson, Highly-purified exosomes and shed microvesicles isolated from the human colon cancer cell line LIM1863 by sequential centrifugal ultrafiltration are biochemically and functionally distinct. Methods 87, 11 (2015)CrossRefPubMed
69.
Zurück zum Zitat D. Choi, J. Lee, G. Park, H. Lim, J. Bang, Y. Kim, K. Kwon, H. Kwon, K. Kim, Y. Gho, Proteomic analysis of microvesicles derived from human colorectal cancer cells. J. Proteome Res. 6, 4646 (2007)CrossRefPubMed D. Choi, J. Lee, G. Park, H. Lim, J. Bang, Y. Kim, K. Kwon, H. Kwon, K. Kim, Y. Gho, Proteomic analysis of microvesicles derived from human colorectal cancer cells. J. Proteome Res. 6, 4646 (2007)CrossRefPubMed
70.
Zurück zum Zitat S. Mathivanan, J. Lim, B. Tauro, H. Ji, R. Moritz, R. Simpson, Proteomics analysis of A33 immunoaffinity-purified exosomes released from the human colon tumor cell line LIM1215 reveals a tissue-specific protein signature. Mol. Cell. Proteomics 9, 197 (2010)CrossRefPubMed S. Mathivanan, J. Lim, B. Tauro, H. Ji, R. Moritz, R. Simpson, Proteomics analysis of A33 immunoaffinity-purified exosomes released from the human colon tumor cell line LIM1215 reveals a tissue-specific protein signature. Mol. Cell. Proteomics 9, 197 (2010)CrossRefPubMed
71.
Zurück zum Zitat R. Borer, C. Lehner, H. Eppenberger, E. Nigg, Major nucleolar proteins shuttle between nucleus and cytoplasm. Cell 56, 379 (1989)CrossRefPubMed R. Borer, C. Lehner, H. Eppenberger, E. Nigg, Major nucleolar proteins shuttle between nucleus and cytoplasm. Cell 56, 379 (1989)CrossRefPubMed
72.
Zurück zum Zitat R. Redner, Variations on a theme: The alternate translocations in APL. Leukemia 16, 1927 (2002)CrossRefPubMed R. Redner, Variations on a theme: The alternate translocations in APL. Leukemia 16, 1927 (2002)CrossRefPubMed
73.
Zurück zum Zitat N. Yoneda-Kato, A. Look, M. Kirstein, M. Valentine, S. Raimondi, K. Cohen, A. Carroll, S. Morris, The t(3;5)(q25.1;q34) of myelodysplastic syndrome and acute myeloid leukemia produces a novel fusion gene, NPM-MLF1. Oncogene 12, 265 (1996)PubMed N. Yoneda-Kato, A. Look, M. Kirstein, M. Valentine, S. Raimondi, K. Cohen, A. Carroll, S. Morris, The t(3;5)(q25.1;q34) of myelodysplastic syndrome and acute myeloid leukemia produces a novel fusion gene, NPM-MLF1. Oncogene 12, 265 (1996)PubMed
74.
Zurück zum Zitat R. Chiarle, J. Gong, I. Guasparri, A. Pesci, J. Cai, J. Liu, W. Simmons, G. Dhall, J. Howes, R. Piva, G. Inghirami, NPM-ALK transgenic mice spontaneously develop T-cell lymphomas and plasma cell tumors. Blood 101, 1919 (2003)CrossRefPubMed R. Chiarle, J. Gong, I. Guasparri, A. Pesci, J. Cai, J. Liu, W. Simmons, G. Dhall, J. Howes, R. Piva, G. Inghirami, NPM-ALK transgenic mice spontaneously develop T-cell lymphomas and plasma cell tumors. Blood 101, 1919 (2003)CrossRefPubMed
75.
Zurück zum Zitat N. van Belzen, M. Diesveld, A. van der Made, Y. Nozawa, W. Dinjens, R. Vlietstra, J. Trapman, F. Bosman, Identification of mRNAs that show modulated expression during colon carcinoma cell differentiation. Eur. J. Biochem. 234, 843 (1995)CrossRefPubMed N. van Belzen, M. Diesveld, A. van der Made, Y. Nozawa, W. Dinjens, R. Vlietstra, J. Trapman, F. Bosman, Identification of mRNAs that show modulated expression during colon carcinoma cell differentiation. Eur. J. Biochem. 234, 843 (1995)CrossRefPubMed
76.
Zurück zum Zitat N. Feuerstein, J. Mond, Identification of a prominent nuclear protein associated with proliferation of normal and malignant B cells. J. Immunol. 139, 1818 (1987)PubMed N. Feuerstein, J. Mond, Identification of a prominent nuclear protein associated with proliferation of normal and malignant B cells. J. Immunol. 139, 1818 (1987)PubMed
77.
Zurück zum Zitat J. Li, X. Zhang, D. Sejas, G. Bagby, Q. Pang, Hypoxia-induced Nucleophosmin protects cell death through inhibition of p53. J. Biol. Chem. 279, 41275 (2004)CrossRefPubMed J. Li, X. Zhang, D. Sejas, G. Bagby, Q. Pang, Hypoxia-induced Nucleophosmin protects cell death through inhibition of p53. J. Biol. Chem. 279, 41275 (2004)CrossRefPubMed
78.
Zurück zum Zitat D. Taylor, C. Gerçel-Taylor, Tumour-derived exosomes and their role in cancer-associated T-cell signalling defects. Br. J. Cancer 92, 305 (2005)CrossRefPubMedPubMedCentral D. Taylor, C. Gerçel-Taylor, Tumour-derived exosomes and their role in cancer-associated T-cell signalling defects. Br. J. Cancer 92, 305 (2005)CrossRefPubMedPubMedCentral
Metadaten
Titel
Secretome profiling of heterotypic spheroids suggests a role of fibroblasts in HIF-1 pathway modulation and colorectal cancer photodynamic resistance
verfasst von
María Julia Lamberti
Mandy Rettel
Jeroen Krijgsveld
Viviana Alicia Rivarola
Natalia Belén Rumie Vittar
Publikationsdatum
12.02.2019
Verlag
Springer Netherlands
Erschienen in
Cellular Oncology / Ausgabe 2/2019
Print ISSN: 2211-3428
Elektronische ISSN: 2211-3436
DOI
https://doi.org/10.1007/s13402-018-00418-8

Weitere Artikel der Ausgabe 2/2019

Cellular Oncology 2/2019 Zur Ausgabe

Neu im Fachgebiet Pathologie